It discusses investigational peptides from a laboratory research perspective and should not be interpreted as medical advice or treatment recommendations
Great oversight, sure, but nowhere near the same strict federal manufacturing rules as big pharma
This does not mean every patient has the same outcome, but it does mean patients should not stop medication abruptly without discussing nutrition, activity, dose strategy, hunger return, and follow-up with a physician
Weight reduction by 5 % to 10 % typically improves these odds, though for people with severe obesity (for example, BMI 35 kg/m), 15 % to 20 % weight loss is a more meaningful target
They are approved for type 2 diabetes management and obesity treatment in patients meeting specific BMI criteria, but their use for lipedema represents off-label prescribing with limited clinical evidence
With a cost of $1,000 per month without insurance, many find it a worthwhile investment, potentially avoiding higher medical costs in the future